Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASCT2 (SLC1A5) is a sodium-dependent antiporter responsible for the uptake and exchange of small neutral amino acids, with a preference for glutamine. It is highly expressed in proliferative tissues and cancer cells, where it plays a key role in glutamine metabolism and mTORC1 signaling. ASCT2 serves as a receptor for certain retroviruses and is considered a potential target for anticancer drug development.
Inhibition of amino acid transport (glutamine)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutral Amino Acid Transporter B(0) (ASCT2).